[Effectiveness of fusidic acid alone and in combination with hydrocortisone-17-butyrate in infected dermatoses].
In a double-blind controlled study with 27 indoor patients good results were achieved in the treatment of infected dermatoses by fusidic acid and by the combination of fusidic acid with hydrocortisone-17-butyrate.
D001424:Bacterial Infections / Q000188:drug therapy*; D003876:Dermatitis, Atopic / Q000188:drug therapy; D003877:Dermatitis, Contact / Q000188:drug therapy; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004485:Eczema / Q000188:drug therapy; D005672:Fusidic Acid / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D003879:Dermatologic Agents; C007975:hydrocortisone-17-butyrate; D005672:Fusidic Acid; D006854:Hydrocortisone
Zur Wirksamkeit von Fusidinsäure als Monopräparat und in Kombination mit Hydrokortison-17-butyrat bei infizierten Dermatosen.